Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Suneva Medical

Request full access

Developing, manufacturing and commercializing novel, differentiated products for the aesthetic markets

San Diego, United StatesFounded 2009Biotech & Life Sciences

About Suneva Medical

Suneva Medical, Inc., founded in 2009 and based in San Diego, California, operates as a commercial-stage medical technology company with a focus on the regenerative aesthetics market. The company develops, manufactures, and commercializes a portfolio of products for physicians and their patients, designed to leverage the body's own restorative capabilities. The business generates revenue by selling its aesthetic products to providers in the dermatology, plastic, and cosmetic surgery markets.

The company's product portfolio has included several notable offerings. Its flagship product, Bellafill®, is a dermal filler with FDA approval for correcting nasolabial folds (smile lines) and moderate to severe, atrophic, distensible facial acne scars on the cheeks. In January 2019, Suneva expanded its regenerative aesthetics portfolio through partnerships with Healeon Medical and Puregraft, LLC, adding innovative PRP (platelet-rich plasma) technology and a fat grafting system. Later, the portfolio grew to include Silhouette Instalift®, resorbable sutures for cosmetic facial procedures, and PlasmaIQ™, a hand-held plasma energy device. However, in October 2024, Tiger Aesthetics Medical, LLC, a division of Tiger BioSciences, acquired select assets from Suneva, including the BellaFill®, Silhouette InstaLift®, and Amplifine™ PRP product lines.

Suneva Medical has a history of significant leadership changes and financing rounds to support its growth. Nicholas L. Teti Jr. served as Chairman and CEO for six years, overseeing the FDA approval of Bellafill for acne scars. In August 2016, Preston Romm was promoted to President and CEO. Patricia Altavilla, a seasoned executive with over 30 years in the aesthetics and medical fields, was appointed CEO in March 2019, succeeding Romm. Her extensive background includes leadership roles at Mentor Corporation, BioForm Medical (now Merz Aesthetics), and ZELTIQ® Aesthetics. The company has secured substantial funding over the years, including a $35 million round in 2014, a $25 million investment from Essex Woodlands in 2016, and has been backed by investors like Polaris Partners, EW Healthcare Partners, and Almirall. In January 2022, Suneva announced a definitive merger agreement with Viveon Health Acquisition Corp., a special purpose acquisition company (SPAC), with plans to trade on the NYSE under the symbol "RNEW", although the deal was later noted as cancelled.

Source: Dealroom company data

At a glance

Status
Operational
Employees
55
Open positions
None listed
Dealroom signal
30.1/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Tech for Hospitals and Clinics, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Sep 2021 $15M $125M Avenue Venture —
LATE VCOther financing May 2020 $25M $100M Undisclosed —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Suneva Medical website traffic

Latest recorded traffic for Suneva Medical is 130 monthly website visits, down 77.2% over the last three months. Suneva Medical's team declined 11.3% over the past year.

Latest monthly visits130 3-month web change-77.2% 1-year team growth-11.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Suneva Medical in the San Diego ecosystem

Live from Dealroom

The Suneva Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later8 investors entered at this stage

Team profiled 22 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States94.1%
🇨🇦 Canada5.9%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Suneva Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Suneva Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.